CACI INTERNATIONAL CLA (CACI) Stock Analysis
Market Closed
Sector: Technology · Industry: Services-Computer Integrated Systems Design
What's happening with CACI
Price History
5-Year Weekly Candlestick Chart
Profile
Strong earnings quality; profitability and valuation lag behind.
How is each axis scored?
- Valuation49/100 · Weak
- P/E vs own history (91th pct)0/25
- FCF yield (4.1%)12/25
- P/S (1.5x)25/25
- EV/EBIT (22.2x)12/25
- Growth55/100 · Moderate
- Revenue CAGR (9.3%)12/25
- Net income CAGR (2.2%)6/25
- EPS CAGR 5Y (5.1%)12/25
- Fwd implied growth (35.6%)25/25
- Profitability42/100 · Weak
- ROIC (7.3%)5/25
- ROE (12.5%)12/25
- Net margin (5.9%)13/25
- Operating margin (9.3%)12/25
- Financial Health51/100 · Moderate
- Altman Z (2.64)18/25
- Current ratio (1.61)18/25
- Interest coverage (4.3x)10/25
- Net cash / debt (D/A 43%)5/25
- Quality92/100 · Strong
- Piotroski F (7/9)22/25
- Beneish M (-2.44)20/25
- FCF conversion (107%)25/25
- Margin stability (σ 0.9%)25/25
About CACI INTERNATIONAL CLA
CACI International Inc is a provider of differentiated Technology and distinctive Expertise to customers in support of national security in the intelligence, defense, and federal civilian sectors, both domestically and internationally. Show more
The demand for its Technology and Expertise is largely driven by the evolving national security and geopolitical environment, increasingly complex network, systems, and information environments in which governments and businesses operate. The Company has two segments: Domestic Operations, which generates maximum revenue and provides Technology and Expertise mainly to the U.S. federal government, and International Operations, which provides Technology and Expertise mainly to international government and commercial customers.
Headquarters: RESTON, VA · Employees: 27,000 · Website ↗
Analyst Consensus
Strong BuyWall Street consensus estimates — not a PMP forecast · Updated Sep 21, 2026
Insider Transactions
Recent SEC Form 4 filings
- BuyGrant / award · filed 2026-08-03+58 sh2026-07-30
- SellOption exercise · filed 2026-07-15-85 sh2026-07-13
- BuyOption exercise · filed 2026-07-15+85 sh2026-07-13
- SellOption exercise · filed 2026-07-15-85 sh2026-07-13
- BuyOption exercise · filed 2026-07-15+85 sh2026-07-13
+3 more recent filings
Key Metrics
Financial snapshot — pillar inputs plus per-share and market context
Valuation
49D+P/E (TTM)26.1xC
Grade C: Exp.Price / TTM EPS (own statements) — vs own 5Y history: 13.3x–28.7x · 91st pct
P/FCF17.9xB
Grade B: FairPrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative
FCF Yield4.1%C
Grade C: LowTTM FCF / Market Cap — vs own 5Y history: 3.1%–10.6% · 16th pct
P/S (TTM)1.53xA
Grade A: CheapPrice / TTM Revenue (own statements) — vs own 5Y history: 0.9x–1.6x · 95th pct
EV/EBIT22.2xC
Grade C: Exp.Enterprise value / TTM EBIT (D&A not in our data) — capital-structure neutral — vs own 5Y history: 13.8x–23.5x · 99th pct
EV/Sales1.9xA
Grade A: CheapEnterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple
Forward P/E19.3xB
Grade B: FairPrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth
P/B Ratio3.27xC
Grade C: Exp.Price to Book Value. Neg. equity = heavy buybacks
PEG Ratio3.20D
Grade D: Exp.Finnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)
Dividend Yield—
TTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress
Payout Ratio—
Dividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable
Profitability
42D+ROIC7.3%D
Grade D: LowNOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat
ROE12.5%C
Grade C: AvgReturn on Equity. Neg. equity = heavy buybacks
ROA5.2%C
Grade C: AvgReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit
Net Margin5.9%C
Grade C: AvgNet Income / Revenue
Operating Margin9.3%D
Grade D: LowTTM EBIT / TTM Revenue
Gross Margin9.3%D
Grade D: LowGross Profit / Revenue
FCF Margin6.3%D
Grade D: LowFCF / Revenue
True FCF Margin5.5%C
Grade C: AvgTTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost
Financial Health
51CAltman Z-Score2.64C
Grade C: Gray zoneBankruptcy risk. >3 Safe, <1.8 Distress
Current Ratio1.61xC
Grade C: OkCurrent Assets/Liabilities
Quick Ratio1.25xA
Grade A: High(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory
Interest Coverage4.3xC
Grade C: OkEBIT/Interest. >10 Strong
Debt Repayment8.6yC
Grade C: AvgYears to repay net debt via FCF
Net Debt/EBIT5.8xD
Grade D: HighLeverage. <2x Low, >4x High
Debt/Equity1.20xC
Grade C: MedDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.
Cash / Debt0.03xD
Grade D: ThinCash covers how much of total debt. >1 = could repay all debt from cash
Growth
55CRevenue CAGR9.3%C
Grade C: OkCompound annual revenue growth (up to 5Y depending on data availability)
Net Income CAGR2.2%D
Grade D: LowCompound annual net income growth (up to 5Y depending on data availability)
EPS CAGR (5Y)5.1%C
Grade C: OkCompound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0
Forward Growth35.6%A
Grade A: HighImplied 1Y EPS growth from forward P/E vs our TTM EPS. Sparse — only where forward estimates exist
Dilution (5Y)-12.4%A
Grade A: BuybacksShare count change over 5Y
SBC / Net Income12.9%C
Grade C: MedStock-based comp/Net income. >30% = dilution risk
SBC / Revenue0.8%A
Grade A: LowTTM stock-based comp / TTM Revenue
Quality
92A+Piotroski F-Score7/9A
Grade A: StrongFinancial strength 0–9. >7 Strong
Beneish M-Score-2.44A
Grade A: SafeEarnings manipulation risk. < -2.22 Safe
FCF Conversion107.4%A
Grade A: StrongFCF / Net Income
Margin Stability0.9%A
Grade A: StableEBIT margin std deviation. Lower = stable
Capex / Revenue1.0%A
Grade A: Asset-lightTTM CapEx / TTM Revenue — high % = capital-hungry business
Asset Turnover0.81xC
Grade C: AvgRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales
Per Share
EPS (TTM)$24.23
Own TTM net income / shares — same earnings basis as P/E
Cash / Share$8.68
Cash & short-term investments per share (Finnhub)
Book Value / Share$201.94
Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks
Balance Sheet
Total Debt$5.13B
Total debt obligations (short + long term)
Cash & Equiv.$158.00M
Cash and short-term investments
Net Debt$4.98B
Total Debt minus Cash. Negative = Net Cash position
Total Equity$4.28B
Shareholders' equity (book value)
Asset / Liability1.58xC
Grade C: AdequateTotal Assets / Total Liabilities
Market
Market Cap$13.99B
Current Market Capitalization
Beta0.57B
Grade B: DefensivePrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings
Takeaway
Priemerné fundamentálne skóre, hraničný Altman Z-skóre 2,64 a dlhšia doba splácania dlhu (8,6 roka) radia CACI medzi priemerne atraktívne investície s limitovaným FCF výnosom na úrovni 4,1 %.
Takes ~8.6 years to repay net debt from free cash flow. · Current P/E of 26.1x sits at the 91st percentile of its historical range.
How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.
Financials as of Mar 2026 · Ratio snapshot Sep 22, 2026
Key Insights: CACI INTERNATIONAL CLA (CACI)
Composite verdict for CACI INTERNATIONAL CLA: Priemerné fundamentálne skóre, hraničný Altman Z-skóre 2,64 a dlhšia doba splácania dlhu (8,6 roka) radia CACI medzi priemerne atraktívne investície s limitovaným FCF výnosom na úrovni 4,1 %.. CACI INTERNATIONAL CLA meets 7 of 9 Piotroski F-Score criteria, placing its fundamental strength in the top tier of US-listed stocks. Altman Z-Score of 2.64 falls in the grey zone (1.81–2.99) — financial distress is unlikely but not ruled out.
- Beneish M-Score of -2.44 suggests a low likelihood of earnings manipulation.
- Takes ~8.6 years to repay net debt from free cash flow.
See how CACI ranks on the Capex Tracker — top 50 capital spenders compared.
No significant market moves for CACI in the last 30 days.
See CACI move history →Frequently Asked Questions about CACI
Is CACI stock a buy right now?
PreMarketPrice's quantitative model rates CACI INTERNATIONAL CLA's financial health at 51/100 — Priemerné fundamentálne skóre, hraničný Altman Z-skóre 2,64 a dlhšia doba splácania dlhu (8,6 roka) radia CACI medzi priemerne atraktívne investície s limitovaným FCF výnosom na úrovni 4,1 %.. This is a data-driven snapshot of fundamentals, not investment advice.
Is CACI stock overvalued?
CACI INTERNATIONAL CLA trades at a trailing P/E of 26.1 and our valuation score rates it 49/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.
When does CACI INTERNATIONAL CLA report earnings?
No confirmed earnings date is currently scheduled for CACI. The Earnings section lists recent reports and updates as dates are announced.
What sector does CACI INTERNATIONAL CLA operate in?
CACI INTERNATIONAL CLA operates in the Technology sector, within the Services-Computer Integrated Systems Design industry. The Related Stocks section lists sector peers for comparison.
What does CACI INTERNATIONAL CLA do?
CACI International Inc is a provider of differentiated Technology and distinctive Expertise to customers in support of national security in the intelligence, defense, and federal civilian sectors, both domestically and internationally.
About CACI INTERNATIONAL CLA (CACI) Stock
CACI INTERNATIONAL CLA (CACI) is a US-listed stock operating in the Technology sector, specifically the Services-Computer Integrated Systems Design industry. Real-time pricing data for CACI INTERNATIONAL CLA is available on this page with a market capitalization of $14.0 billion. The financial health score for CACI is 51/100, which indicates moderate financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for CACI stock.
CACI Stock Analysis & Key Metrics
On PreMarketPrice, you can track CACI INTERNATIONAL CLA (CACI) across multiple dimensions:
- Pre-market price & movement: Real-time CACI stock price with percentage change, updated continuously during pre-market and regular trading hours.
- Valuation & P/E history: Historical P/E, P/S, and P/B ratios for CACI with trend analysis and normalized valuation multiples.
- Financial statements: Revenue, net income, assets, liabilities, and equity for CACI INTERNATIONAL CLA across multiple reporting periods.
- Financial health score: A composite score of 51/100 based on Altman Z-Score, Piotroski F-Score, profitability, and leverage metrics for CACI.
- Sector peers: Compare CACI against 10 other technology stocks on key financial metrics.
Is CACI a Good Stock to Buy?
This page provides data-driven analysis to help you evaluate CACI INTERNATIONAL CLA (CACI) as an investment. The financial health score of 51/100 suggests moderate financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.
Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.CACI INTERNATIONAL CLA (CACI) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.